Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9456
pubmed:dateCreated
2005-1-24
pubmed:abstractText
Latvia has one of the highest rates of multidrug-resistant tuberculosis (MDRTB). Our aim was to assess treatment outcomes for the first full cohort of MDRTB patients treated under Latvia's DOTS-Plus strategy following WHO guidelines.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1474-547X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
365
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
318-26
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15664227-Adolescent, pubmed-meshheading:15664227-Adult, pubmed-meshheading:15664227-Aged, pubmed-meshheading:15664227-Antitubercular Agents, pubmed-meshheading:15664227-Directly Observed Therapy, pubmed-meshheading:15664227-Drug Therapy, Combination, pubmed-meshheading:15664227-Female, pubmed-meshheading:15664227-Humans, pubmed-meshheading:15664227-Latvia, pubmed-meshheading:15664227-Male, pubmed-meshheading:15664227-Microbial Sensitivity Tests, pubmed-meshheading:15664227-Middle Aged, pubmed-meshheading:15664227-Mycobacterium tuberculosis, pubmed-meshheading:15664227-Risk Factors, pubmed-meshheading:15664227-Survival Rate, pubmed-meshheading:15664227-Treatment Outcome, pubmed-meshheading:15664227-Tuberculosis, Multidrug-Resistant, pubmed-meshheading:15664227-Tuberculosis, Pulmonary
pubmed:articleTitle
Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.
pubmed:affiliation
State Centre of Tuberculosis and Lung Diseases, Riga, Latvia. vaira@tuberculosis.lv
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't